Viable germ cell tumor and teratoma can be distinguished from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens by a combination of microRNA-371a-3p and 375-5p.

被引：0
|
作者：
Nestler, Tim
Kremer, Lara
von Brandenstein, Melanie
Koeditz, Barbara
Paffenholz, Pia
Hellmich, Martin
Pfister, David
Heidenreich, Axel
机构：
[1] Univ Hosp Cologne, Dept Urol, Cologne, Germany
[2] Univ Hosp Cologne, Dept Urol & Urooncol, Cologne, Germany
[3] Univ Cologne, Inst Med Stat & Computat Biol, Cologne, Germany
[4] Univ Hosp Cologne, Cologne, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
421
引用
收藏
页数：2
相关论文
共 14 条
  • [1] The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
    Nestler, T.
    Kremer, L.
    Von Brandenstein, M.
    Wittersheim, M.
    Koeditz, B.
    Paffenholz, P.
    Hellmich, M.
    Pfister, D.
    Heidenreich, A.
    EUROPEAN UROLOGY, 2021, 79 : S906 - S906
  • [2] THE COMBINATION OF MICRORNA-371A-3P AND 375-5P CAN DISTINGUISH VIABLE GERM CELL TUMOR AND TERATOMA FROM NECROSIS IN POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION SPECIMENS
    Nestler, Tim
    Kremer, Lara
    von Brandenstein, Melanie
    Wittersheim, Maike
    Koeditz, Barbara
    Paffenholz, Pia
    Hellmich, Martin
    Pfister, David
    Heidenreich, Axel
    JOURNAL OF UROLOGY, 2021, 206 : E714 - E714
  • [3] The combination of microRNA-371a-3p and 375-5p can distinguish viable germ cell tumor and teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection specimens
    Kremer, Lara
    von Brandenstein, Melanie
    Wittersheim, Maike
    Koeditz, Barbara
    Paffenholz, Pia
    Hellmich, Martin
    Pfister, David
    Heidenreich, Axel
    Nestler, Tim
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (04)
  • [4] Serum microRNA-371a-3p levels to predict viable germ cell tumor in chemotherapy-naive patients undergoing retroperitoneal lymph node dissection
    Singla, Nirmish
    Lafin, John T.
    Woldu, Solomon L.
    Lotan, Yair
    Lewis, Cheryl
    Majmudar, Kuntal
    Savalyeva, Anna
    Kenigsberg, Alexander P.
    Kapur, Payal
    Margulis, Vitaly
    Strand, Douglas
    Murray, Matthew
    Amatruda, James F.
    Bagrodia, Aditya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Serum MicroRNA-371a-3p Levels Predict Viable Germ Cell Tumor in Chemotherapy-naive Patients Undergoing Retroperitoneal Lymph Node Dissection
    Lafin, John T.
    Singla, Nirmish
    Woldu, Solomon L.
    Lotan, Yair
    Lewis, Cheryl M.
    Majmudar, Kuntal
    Savelyeva, Anna
    Kapur, Payal
    Margulis, Vitaly
    Strand, Douglas W.
    Murray, Matthew J.
    Amatruda, James F.
    Bagrodia, Aditya
    EUROPEAN UROLOGY, 2020, 77 (02) : 290 - 292
  • [6] Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
    Taza, Fadi
    Chovanec, Michal
    Snavely, Anna
    Hanna, Nasser H.
    Cary, Clint
    Masterson, Timothy A.
    Foster, Richard S.
    Einhorn, Lawrence H.
    Albany, Costantine
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (12) : 1338 - +
  • [7] Re: Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients with Metastatic Germ Cell Tumor
    不详
    JOURNAL OF UROLOGY, 2022, 207 (02): : 469 - 470
  • [8] Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen - Can it be predicted using clinical parameters?
    Spiess, Philippe E.
    Brown, Gordon A.
    Pisters, Louis L.
    Liu, Ping
    Tu, Shi-Ming
    Evans, James G.
    Kamat, Ashish M.
    Black, Peter
    Tannir, Nizar M.
    CANCER, 2006, 107 (07) : 1503 - 1510
  • [9] Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection - Can we predict patients at risk of disease progression?
    Spiess, Philippe E.
    Tannir, Nizar M.
    Tu, Shi-Ming
    Brown, Gordon A.
    Liu, Ping
    Kamat, Ashish M.
    Wood, Christopher G.
    Evans, James G.
    Pisters, Louis L.
    CANCER, 2007, 110 (12) : 2700 - 2708
  • [10] Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection
    Konneh, Bendu
    Lafin, John T.
    Howard, Jeffrey
    Gerald, Thomas
    Amini, Armon
    Savelyeva, Anna
    Woldu, Solomon L.
    Lewis, Cheryl M.
    Jia, Liwei
    Margulis, Vitaly
    Coleman, Nicholas
    Scarpini, Cinzia
    Frazier, A. Lindsay
    Murray, Matthew J.
    Amatruda, James F.
    Bagrodia, Aditya
    ANDROLOGY, 2023, 11 (04) : 634 - 640
12